2B3-101
Brain Cancer
Clinical DevelopmentActive
Key Facts
About 2-BBB Medicines
2-BBB Medicines is a private, clinical-stage biotech leveraging its proprietary G-Technology® liposomal platform to enhance drug delivery to the central nervous system and eyes. Originating from Leiden University, the company partners with pharma and biotech firms to develop improved therapies for oncology, neurology, and retinal diseases. Its strategy centers on de-risking development by applying its delivery technology to known compounds, with several partnered programs already in the clinic.
View full company profileTherapeutic Areas
Other Brain Cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| PanGIA Brain | PanGIA Biotech | Pre-clinical |